Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bayer acquires Blackford Analysis to bolster radiology portfolio

Ruchika Sharma22 Jan 2023 10:00 AM IST

The acquisition is expected to close later this year, pending the satisfaction of customary closing conditions.

Lupin Nagpur facility completes USFDA inspection

Lupin recalls 16,056 bottles of tuberculosis drug Rifampin in US

Ruchika Sharma21 Jan 2023 2:49 PM IST

The affected lot has been produced at Lupin's Aurangabad plant and marketed in the US by Baltimore-based Lupin Pharmaceuticals.

Allahabad HC to hear petition against Dolo manufacturer on Feb 20

Ruchika Sharma21 Jan 2023 2:21 PM IST

Prayagraj: A petition against the pharmaceutical company manufacturing Dolo-650 tablets was filed with the Allahabad High Court in Uttar Pradesh on...

USFDA nod to JnJ Tremfya for Crohns disease

Johnson and Johnson arm to pay USD 9.75 million to resolve kickback allegations

Ruchika Sharma21 Jan 2023 1:15 PM IST

The surgeon and the hospitals in which the procedures were performed did not pay for the products.

Bharat Biotech founder Dr Krishna Ella bats for incentives, tax breaks for patented products, innovation

Ruchika Sharma21 Jan 2023 12:15 PM IST

Queried about the need for three doses of the COVID-19 vaccine instead of just one, Ella said his company was working on the issue.

Centre to introduce research linked incentive scheme to cover RnD costs for biotech products: DCGI Dr V G Somani

Ruchika Sharma21 Jan 2023 11:23 AM IST

Underscoring the importance of policy reforms, innovation, and research and development, he said the government has taken several initiatives to aid...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddy's labs completes clinical studies of Rituximab biosimilar for filing in US, Europe

Ruchika Sharma20 Jan 2023 3:30 PM IST

With the successful completion of these clinical studies, Dr. Reddy’s is now preparing to file Biologics License Application (BLA) / Marketing...

Sanofi gets approval for 2 rare hematologic diseases medicines in China

Sanofi plans to unveil blood disorder drug this year: Report

Ruchika Sharma20 Jan 2023 2:30 PM IST

France: French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told...

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis

USFDA rejects accelerated approval for Eli Lilly Alzheimer's drug Donanemab

Ruchika Sharma20 Jan 2023 1:30 PM IST

"I don't think it says anything negative about the drug. It was just a manifestation of the study design," said Dr. Ronald Petersen, an Alzheimer's...

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

Sun Pharma to buy Concert Pharma for Rs 4678 crore

Ruchika Sharma20 Jan 2023 12:26 PM IST

"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the first half of 2023," the...

Wipro GE HealthCare ropes in Chaitanya Sarawate as new MD

Ruchika Sharma20 Jan 2023 12:06 PM IST

Prior to this, he was the Chief Marketing & Strategy Officer for AKA (ASEAN, Korea, Australia & New Zealand).

Janssen, Global Partners to discontinue Phase 3 Mosaico HIV vaccine trial

Ruchika Sharma19 Jan 2023 4:15 PM IST

Leiden: The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, has announced the results of an...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok